Last update 12 Dec 2024

Resiquimod

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Resiquimod, CD 11301., CD-11301
+ [7]
Mechanism
TLR7 antagonists(Toll like receptor 7 antagonists), TLR8 antagonists(Toll like receptor 8 antagonists)
Inactive Indication
Originator Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC17H22N4O2
InChIKeyBXNMTOQRYBFHNZ-UHFFFAOYSA-N
CAS Registry144875-48-9

External Link

KEGGWikiATCDrug Bank
-Resiquimod-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Muscle Invasive Bladder NeoplasmsPhase 2
US
11 Jul 2023
Recurrent Bladder CancerPhase 2
US
11 Jul 2023
Cutaneous T-Cell LymphomaPhase 2
US
19 Dec 2017
Cutaneous T-Cell LymphomaPhase 2
FR
19 Dec 2017
Cutaneous T-Cell LymphomaPhase 2
DE
19 Dec 2017
Basal Cell CarcinomaPhase 2
DE
01 Feb 2013
Basal Cell CarcinomaPhase 2
CH
01 Feb 2013
Actinic KeratosisPhase 2
DE
01 May 2012
Actinic KeratosisPhase 2
CH
01 May 2012
Hepatitis BPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
47
(Group 1: GP100 and MAGE-3 + R848)
eallbsrbfn(ydotzpzcce) = trzxqmxiyu qgrlbawmtl (fljtzmmnwq, wqwdatlcqp - ubjwzgpmmo)
-
13 Aug 2021
MAGE-3+gp100
(Group 2: GP100 and MAGE-3)
eallbsrbfn(ydotzpzcce) = igtpjgtjrc qgrlbawmtl (fljtzmmnwq, xrrgsklbbj - mginrdbero)
Phase 1/2
4
(0.06% Resiquimod Gel - A)
xfraorsgky(fbcwuagrsp) = qurzffjrpn mxgsnoknqa (rtotbgfslq, ncsaaaelbl - lryhdlzbdv)
-
22 Jun 2016
(0.06% Resiquimod Gel - B)
xfraorsgky(fbcwuagrsp) = uprbnftled mxgsnoknqa (rtotbgfslq, jozotwvjtj - ngambbkzhl)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free